🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Albricias! The long-awaited Spanish guideline on methods for economic evaluation of health technologies is finally here! Amazing news - thanks CAPF Ministerio de Sanidad and all the experts who contributed to it 😉

What Interventions are Cost Effective in Reducing Violence Against #Women? A Scoping Review link.springer.com/article/10.100… #InternationalWomensDay #InternationalWomensDay2024

AHEHP has a new collection of papers considering #environmental 🌏 impacts in #HealthEconomics and #HTA link.springer.com/collections/ji… It's great to see more work emerging in this neglected area Please reach out to me if you have a potential paper for this collection

For #EarthDay2024 I thought I'd share a collection of articles, research, and talks I've compiled recently that are related to healthcare and climate change. There's links to lots of great work and researchers... check it out if you're interested! sites.google.com/view/climatean…

Fun little editorial from Matt Franklin and me on the obsession with decision modelling in economic evaluations. We're presenting more on this at EuHEA if you'd like to come and voice your divergent views rdcu.be/dFOfD

The understanding, purpose, and need of within-trial economic evaluations has somewhat been lost. Rachael Maree Hunter and I have provided an updated perspective for justifying within-trial economic evaluations alongside or instead of decision-analytic models doi.org/10.1007/s41669…

I'm presenting a webinar for ISPOR New Zealand on 26 June at 0930 NZ time on "An introduction to conducting discrete choice experiments in healthcare" Details and sign-up here: ispor.org.nz/post/ispor-nz-… #healtheconomics

I am honored to be newly appointed to the Applied Health Economics and Health Policy editorial board. Check out the July 2024 issue now: link.springer.com/journal/40258/…. Economic evaluations, systematic reviews, opinion pieces, and an application piece on disseminating #HEOR.

Very excited to be joining the editorial board of Applied Health Economics and Health Policy (Tim Wrightson ☮)! I'm incredibly fortunate to be able to help out with a journal and to work with colleagues I hold in high regard. You can check out the latest issue here:

Specialty DMARDs (TNFi, B cell, & JAKi) were found to require >75% discount to be cost-effective for #RA in India compared to csDMARDs, in a great CUA study by Madhumitha Haridoss & Bhavani Shankara B et al from India in Tim Wrightson ☮. #PharmacoEcon #RheumX link.springer.com/article/10.100…

"What do you mean by value?" an often asked question. Alice Minhinnick attempts to answer this in her first 🥇MD paper doi.org/10.1007/s40258… published in Tim Wrightson ☮

We are happy to share the paper entitled "Use of cost-effectiveness thresholds in healthcare public policy: progress and challenges" in Applied Health Economics and Health Policy ( (Tim Wrightson ☮). Research with Oscar Espinosa and Instituto de Evaluación Tecnológica en Salud team. doi.org/10.1007/s40258…

We recently published the 500th article in PharmacoEconomics Open! 🎉 Thank you to everyone who has contributed to the journal to help us reach this milestone, especially our authors, reviewers and editorial board members! link.springer.com/journal/41669/…

Most of the articles published in AHEHP in 2023 were related to at least one Sustainable Development Goal (#SDG). The same goes for our other three Adis #HEOR journals, PharmacoEconomics, The Patient and PharmacoEconomics Open. link.springer.com/journal/40258/…

Happy New Season! Depending on where you are, that means Happy Spring/Autumn/Fall 😀 Here's the September issue of AHEHP. Thank you to the authors for choosing to publish these interesting articles in in AHEHP! 🙏 link.springer.com/journal/40258/…

The September issue of PharmacoEconomics Open includes several articles that contribute to the journal's collections on #OpenSourceModels and #Protocols. We welcome more submissions to these open/ongoing collections. link.springer.com/journal/41669/… #HEOR

Lack of health-related quality of life data for children with rare/genetic conditions poses challenges to understanding impacts of early detection. We highlight importance of collecting HRQoL data to inform (genomic) newborn screening decisions. link.springer.com/article/10.100…

Everything you need to know about the Short Form 6 Dimensions (SF-6D) can be found in this new paper by Clara Mukuria et al. link.springer.com/article/10.100… #SF6D John Brazier